31 Dingjiang Road
Jianggan District
Hangzhou 310016
China
86 571 8580 2712
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 450
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Biao Jin | Chairman and Chief Executive Officer | 19.06k | N/A | 1948 |
Ms. Lin Hui | Chief Financial Officer and Principal Accounting Officer | 12.7k | N/A | 1966 |
Mr. Yue Jun Jiang | Chief of Investment Department and Secretary | N/A | N/A | 1975 |
Mr. Qiu Jiajun | Member of Compensation Committee and Director | N/A | N/A | 1966 |
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Aida Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.